Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An instance of porencephaly that is caused by an inherited modification of the individual's genome.
No HPO annotations are available for this condition.
COL4A1-related disorders cover a spectrum of overlapping phenotypes characterized by a small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (congenital cataract, retinal arterial tortuosity, eye anterior segment anomaly of Axenfeld-Rieger type) and systemic findings (muscle cramps and/or serum CK elevation, kidney involvement, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, hemolytic anemia).
COL4A1-related disorders cover a spectrum of overlapping phenotypes characterized by a small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (congenital cataract, retinal arterial tortuosity, eye anterior segment anomaly of Axenfeld-Rieger type) and systemic findings (muscle cramps and/or serum creatine kinase (CK) elevation, kidney involvement, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia).
A COL4A1-related disorder should be suspected in individuals with any of the following phenotypes, which have overlapping features:
No approved treatments are currently available for familial porencephaly. The disease remains an area of unmet medical need.
To establish the extent of disease and needs in an individual diagnosed with COL4A1-related disorders, the following are recommended:
Brain MRI including T1-weighted saggital, T2-weighted axial, and FLAIR axial images
The interval at which individuals with COL4A1-related disorders should be seen for follow up depends on the severity and type of symptoms. Annual clinical evaluation is reasonable. Regular brain imaging can be proposed, especially to evaluate the size of asymptomatic cerebral aneurysms.
Source: GeneReviews — "COL4A1-Related Disorders"
No clinical trials have been registered for familial porencephaly.
3 publications have been identified in PubMed for familial porencephaly. Research spans Case Report / Case Series (67%) and Review / Meta-Analysis (33%).
Massoudi D (2025). [PMID: 40745060](https://pubmed.ncbi.nlm.nih.gov/40745060/). *Nature reviews. Nephrology*. [Review / Meta-Analysis]
Olarewaju BA (2025). [PMID: 39679724](https://pubmed.ncbi.nlm.nih.gov/39679724/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Gupta T (2024). [PMID: 39416588](https://pubmed.ncbi.nlm.nih.gov/39416588/). *Cureus*. [Case Report / Case Series]
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 2:07 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Autosomal dominant familial porencephaly related to COL4A1 pathogenic variants has been reported in more than 50 individuals [, , , , ]. This condition is characterized by the presence of fluid-filled cavities in the brain, caused by antenatal or perinatal parenchymal hemorrhage and detected by ei...
Source: GeneReviews — "COL4A1-Related Disorders"
Source: GeneReviews — "COL4A1-Related Disorders"
COL4A2-related porencephaly and intracerebral hemorrhages. Seven heterozygous COL4A2 pathogenic variants have been characterized in individuals with either porencephaly (porencephaly type 2; OMIM 614483) or intracerebral hemorrhage (OMIM 614519). Neurologic presentation of individuals with porencephaly type 2 was similar to that observed in COL4A1-related porencephaly . Four patients presented with adult-onset intracerebral hemorrhage . Variably present extracerebral symptoms included cerebellar and optic atrophy, cataracts, intracranial aneurysms, nephropathy, and myopathy .
Source: GeneReviews — "COL4A1-Related Disorders"
Brain angiographic CT scan
Ophthalmologic examination including fundoscopic examination and slit-lamp examination
Kidney and liver ultrasound examination or CT
Measurement of serum CK concentration
Measurement of serum creatinine concentration and estimation of the glomerular filtration rate
Evaluation for the presence of hematuria
Electrocardiogram (EKG); echocardiography and ambulatory EKG monitoring in individuals presenting with palpitations
Consultation with a clinical geneticist and/or genetic counselor
Hypertensive individuals must be treated to reduce the global risk of stroke. Supportive care including practical help, emotional support, and counseling are appropriate for affected individuals and their families. No specific support exists for individuals with COL4A1-related disorders.
Source: GeneReviews — "COL4A1-Related Disorders"
The following should be avoided:
Smoking because it increases the global risk of stroke
Hypertension because it increases the risk of stroke
Sustained head pressure during birth or postnatal physical activities that may cause head trauma
Anticoagulant use
Source: GeneReviews — "COL4A1-Related Disorders"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "COL4A1-Related Disorders"
View trials for familial porencephaly